Funding round
Enveda Series B
Enveda, which works in drug discovery and development in Boulder, raised $68M in a Series B round announced on 21 Dec 2022, led by Dimension. 13 firms took part. It is Enveda's third venture round on record; the one before was a Series A in Jun 2021.
$68M
Amount raised
Not disclosed
Post-money valuation
13
Investors
1 lead
Valuation
What this round says about the price
Enveda did not disclose a valuation in this round. It came 18 months after Enveda's Series A. It is 9.5% of the $715M Enveda has raised in the venture rounds on record. Enveda raised again 23 months later: a Series C round of $130M in Nov 2024. Its next priced round, a Series E in Sep 2026, valued it at $2.00B.
Enveda's funding rounds
Enveda has 6 venture rounds on record. This one is highlighted.
- Seed 27 Dec 2020, led by True Ventures $4.9M
- Series A 22 Jun 2021, led by Lux Capital $51M
- Series B this round 21 Dec 2022, led by Dimension $68M
- Series C 21 Nov 2024, led by Kinnevik and FPV Ventures $130M
- Series D 4 Sep 2025, led by Premji Invest $150M
- Series E 23 Sep 2026, led by Catalio Capital Management $311M$2.00B post-money
Investors
Who put money in
Dimension led the round with 12 other firms.
Lead investor
- backs 24 venture-backed companies new investor
Also in the round
- backs 39 venture-backed companies new investor
- backs 32 venture-backed companies new investor
- backs 3 venture-backed companies new investor
- backs 24 venture-backed companies new investor
- Allen & Co new investor
- backs 53 venture-backed companies new investor
- backs 158 venture-backed companies new investor
- Lux Capital backs 194 venture-backed companies new investor
- backs 24 venture-backed companies new investor
- backs 42 venture-backed companies new investor
- Two Sigma Ventures backs 60 venture-backed companies new investor
- Silicon Valley Bank new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development.
- Product development
Comparable rounds
How it compares
71 Series B rounds in Biotechnology within a year either side disclosed an amount; the median was $60M, and this round was close to the median. The closest in time, other companies' Series B rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 14 Dec 2022 | $30M | not disclosed | M Ventures and Pfizer Ventures |
| Biotechnology | 28 Dec 2022 | $262K | not disclosed | DBJ Capital |
| Biotechnology | 5 Jan 2023 | $175M | not disclosed | Canada Pension Plan Investment Board |
| Colossal Biotechnology | 31 Jan 2023 | $150M | not disclosed | United States Innovative Technology and Breyer Capital |
| Biotechnology | 5 Jan 2023 | $85M | not disclosed | Arix Bioscience and 5AM Ventures |
| Biotechnology | 26 Jan 2023 | $49M | not disclosed | Pfizer Ventures and Earlybird |
| Biotechnology | 14 Nov 2022 | $28M | not disclosed | Shanghai FTZ Fund |
| Biotechnology | 19 Jan 2023 | $10M | not disclosed | not named |
Sources
Where this comes from
Reported by 2 sources.
Questions
Frequently asked
How much did Enveda raise in its Series B round?
Enveda raised $68M in its Series B round, announced in Dec 2022.
Who led Enveda's Series B round?
Dimension led it, with FPV Ventures, JAZZ Venture Partners, Level VC, Amino Collective and Allen & Co and 7 more.
What was Enveda's valuation at the Series B round?
It was not disclosed.
How does it compare with other Series B rounds in Biotechnology?
71 Series B rounds in Biotechnology within a year either side disclosed an amount; the median was $60M, and this round was close to the median.
Did Enveda raise again after this round?
Yes: a Series C round in Nov 2024 of $130M.